Notice of Republication
This article was republished on January 22, 2024, to correct error in the data availability statement: Personal email addresses of multiple personnel were erroneously provided in the data availability statement. An incorrect version of the S1 File was also published in error. The publisher apologises for these errors. Please download this article again to view the correct version.
Reference
- 1. Gupta A, Juneja S, Babawale V, Rustam Majidovich N, Ndjeka N, Thi Mai Nguyen P, et al. (2024) Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026. PLoS ONE 19(1): e0296448. https://doi.org/10.1371/journal.pone.0296448 pmid:38180980
Citation: The PLOS ONE Staff (2024) Correction: Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026. PLoS ONE 19(1): e0298250. https://doi.org/10.1371/journal.pone.0298250
Published: January 31, 2024
Copyright: © 2024 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.